Form 8-K - Current report:
SEC Accession No. 0001104659-23-036246
Filing Date
2023-03-24
Accepted
2023-03-24 07:10:51
Documents
14
Period of Report
2023-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2310372d1_8k.htm   iXBRL 8-K 27776
2 EXHIBIT 99.1 tm2310372d1_ex99-1.htm EX-99.1 115604
6 GRAPHIC tm2310372d1_ex99-1img01.jpg GRAPHIC 3359
  Complete submission text file 0001104659-23-036246.txt   336120

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lptx-20230324.xsd EX-101.SCH 3028
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20230324_lab.xml EX-101.LAB 34477
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20230324_pre.xml EX-101.PRE 22592
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2310372d1_8k_htm.xml XML 3598
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 23757642
SIC: 2834 Pharmaceutical Preparations